Related Experiment Video

Updated: Aug 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lipid lowering in patients with coronary artery disease: low density lipoprotein cholesterol and beyond

J Davignon

    Evidence-Based Cardiovascular Medicine
    |June 1, 1997
    PubMed

    Insights

    Physicians should now focus on factors beyond LDL-C reduction for preventing atherosclerotic vascular complications. A comprehensive approach including triglyceride-rich lipoproteins (TRLs) and thrombotic factors is crucial for managing cardiovascular risk in CAD patients.

    Area of Science:

    • Cardiovascular Medicine
    • Lipid Metabolism
    • Thrombosis and Hemostasis

    Background:

    • Low-density lipoprotein cholesterol (LDL-C) reduction is pivotal for preventing atherosclerotic vascular complications.
    • Current therapeutic strategies increasingly acknowledge the limitations of solely focusing on LDL-C.
    • A paradigm shift is emerging towards a more holistic cardiovascular risk management approach.

    Discussion:

    • Triglyceride-rich lipoproteins (TRLs) and remnant lipoproteins represent significant contributors to residual cardiovascular risk.
    • Thrombotic risk factors and impaired fibrinolysis are critical elements often overlooked in standard care.
    • Integrating these factors into patient management is essential for optimizing outcomes.

    Key Insights:

    • Beyond LDL-C, TRLs and remnant lipoproteins require greater clinical attention.
    • Thrombotic factors and fibrinolysis are key modulators of cardiovascular risk.
    • A multifactorial risk management strategy is necessary for coronary artery disease (CAD) patients.

    Outlook:

    • Future research should explore integrated therapeutic targets for TRLs, thrombosis, and fibrinolysis.
    • Clinical guidelines may evolve to incorporate a broader spectrum of risk factors.
    • Personalized medicine approaches will likely emphasize comprehensive risk assessment beyond LDL-C.

    Related Concept Videos

    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

    Blood Studies for Cardiovascular System III: Serum Lipid Profile

    Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
    Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
    Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
    Lipids: Dietary Sources and Requirements01:18

    Lipids: Dietary Sources and Requirements

    Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...